Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Textiles Press Releases.
Press releases published on August 14, 2025
Skeena Gold & Silver Reports Q2 2025 Financial Results
GlobeNewswire
·
August 14, 2025
VANCOUVER, British Columbia, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Skeena Resources Limited (TSX: SKE, NYSE: SKE) (“Skeena Gold …
INVO Fertility Announces Second Quarter 2025 Financial Results
GlobeNewswire
·
August 14, 2025
SARASOTA, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- INVO Fertility, Inc. (Nasdaq: IVF) (“INVO Fertility” or the “Company”), a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition and …
Brilliant Earth Announces Participation in Upcoming Investor Conferences
GlobeNewswire
·
August 14, 2025
SAN FRANCISCO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Brilliant Earth Group, Inc. (“Brilliant Earth” or the “Company”) (NASDAQ: BRLT), an innovative, global leader in ethically sourced fine jewelry, today announced that the Company will participate in several …
COSCIENS Biopharma Inc. Reports Second Quarter 2025 Financial Results and Provides Strategic Initiatives Update
GlobeNewswire
·
August 14, 2025
COSCIENS Board of Directors approves a plan to voluntarily delist from Nasdaq, while retaining the Company’s listing on the TSX TORONTO, ONTARIO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “ …
NBC Securities Welcomes Aldyn Capital Group to Its Expanding National Advisor Network
GlobeNewswire
·
August 14, 2025
BIRMINGHAM, Ala., Aug. 14, 2025 (GLOBE NEWSWIRE) -- NBC Securities, Inc. (“NBCS”) is proud to announce that Aldyn Capital Group, a premier wealth management practice based in Louisville, Kentucky, has officially joined its growing national network of …
Appili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 2026
GlobeNewswire
·
August 14, 2025
Submitted two additional U.S. government funding proposals during the quarter, bringing the total proposals to US$137 million Accepted as a new member of U.S. Medical CBRN Defense Consortium, strengthening government and biodefense partnerships HALIFAX, …
Regional Health Properties, Inc. and SunLink Health Systems, Inc. Complete Merger
GlobeNewswire
·
August 14, 2025
Atlanta, GA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (“Regional”) (OTCQB: RHEP) (OTCQB: RHEPA) today announced the completion of the merger of SunLink Health Systems, Inc. (“SunLink”) with and into Regional, with Regional …
Teladoc Health Acquires Telecare, Expanding Access to Specialist and Allied Health Care for Australians in Public and Private Health
GlobeNewswire
·
August 14, 2025
MELBOURNE, Australia, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today announced it has acquired Telecare, an innovative, Australian tech-enabled provider of specialist and allied health care via …
Millicom (Tigo) Reaches Strategic Agreement with EPM to facilitate Merger Process with ColTel
GlobeNewswire
·
August 14, 2025
Millicom (Tigo) Reaches Strategic Agreement with EPM to facilitate Merger Process with ColTel Luxembourg, August 14, 2025 – Millicom (Tigo) today announced a key agreement with Empresas Públicas de Medellín (EPM) that advances its acquisition strategy in …
Hesai Group Reports Second Quarter 2025 Unaudited Financial Results
GlobeNewswire
·
August 14, 2025
Quarterly net revenues were RMB706.4 million (US$98.6 million)1 Quarterly lidar shipments were 352,095 units Quarterly net income was RMB44.1 million (US$6.2 million) SHANGHAI, China, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Hesai Group (“Hesai” or the “Company …
Rein Therapeutics to Present Novel IPF Science and Clinical Development Insights at IPF Summit 2025
GlobeNewswire
·
August 14, 2025
AUSTIN, Texas, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Rein Therapeutics ("Rein") (NASDAQ: RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs in orphan pulmonary and fibrosis …
BioSyent Schedules Q2 and H1 2025 Earnings Release for August 21, 2025
GlobeNewswire
·
August 14, 2025
MISSISSAUGA, Ontario, Aug. 14, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months and six months ended June 30, 2025 on Thursday, August 21, 2025 after market …
Emerita Resources Announces Concurrent Offering
GlobeNewswire
·
August 14, 2025
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT AUTHORIZED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Emerita Resources Corp. (“Emerita” …
CELOXFI Implements Military-Grade Security Protocols, Achieves 100% User Asset Insurance Coverage
GlobeNewswire
·
August 14, 2025
GOLDEN, CO , Aug. 14, 2025 (GLOBE NEWSWIRE) -- Celoxfi, the AI-powered crypto asset exchange, today announced a landmark upgrade to its security infrastructure, setting a new industry benchmark for user protection. The platform has secured 100% insurance …
Veea Inc. Announces Closing of $9.2 Million Public Offering
GlobeNewswire
·
August 14, 2025
NEW YORK, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Veea Inc. (NASDAQ: VEEA) (“Veea” or the “Company”), a leader in intelligent edge infrastructure, announced the closing of its public offering of an aggregate of 9,189,096 shares of common stock and warrants to …
Shopkhoj Showcases the Tourist Spots in Royal Jaipur
EIN Presswire
·
August 14, 2025
Shopkhoj Showcases "Jaipur: The Royal …
Range Impact Reports 2Q 2025 Financial Results
GlobeNewswire
·
August 14, 2025
Cleveland, Ohio, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: RNGE) (“Range Impact” or the “Company”), a public impact investing company dedicated to acquiring, reclaiming and repurposing mine sites in Appalachia, reports its results for …
Inhibikase Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Activity
GlobeNewswire
·
August 14, 2025
BOSTON and ATLANTA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing therapeutics to modify the course of cardiopulmonary diseases namely, …
Invivyd Reports Second Quarter 2025 Financial Results and Recent Business Highlights
GlobeNewswire
·
August 14, 2025
PEMGARDA® (pemivibart) net product revenue of $11.8 million reported for Q2 2025, representing 413% growth year-over-year Invivyd’s target of near-term profitability (1H 2025) was not met but remains possible with the upcoming respiratory virus season …
Invivyd Aligns with U.S. FDA on Rapid Pathway to Full Approval (BLA) of Vaccine Alternative Monoclonal Antibody VYD2311 to Protect American Adults and Adolescents from COVID-19
GlobeNewswire
·
August 14, 2025
Alignment follows Type C meeting for VYD2311 as previously disclosed BLA pathway for VYD2311 to be supported by a single, Phase 2/3 randomized, double-blind, placebo-controlled trial with a primary endpoint of reduction in symptomatic COVID-19, resembling …